The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Objectives/Hypothesis
Recent research has examined the nasal microbiome in rhinosinusitis and nondiseased states. Given immunologic alterations in allergic rhinitis (AR) and after allergen immunotherapy (IT), we evaluated the nasal microbiome in these conditions.
Study Design
Cross‐sectional comparison.
Methods
In this cross‐sectional study, nasal swabs for microbiome analysis were collected...
Sublingual immunotherapy (SLIT) clinical trials demonstrate clinical efficacy and safety in patients with allergic rhinitis/rhinoconjunctivitis (AR). In 2014, the Unites States Food and Drug Administration approved two grass pollen SLIT tablets for the treatment of AR, as well as one short ragweed SLIT tablet. With the availability of single-allergen SLIT tablets for allergic individuals in the US,...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.